Long non-coding RNA-ROR mediates the reprogramming in cardiac hypertrophy

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Jiang, Feng ^a   Zhou, Xiangyu ^b   Huang, Jing ^a  

^a THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MIRN133 MICRORNA, MOUSE; PHENYLEPHRINE;

ANIMAL; C57BL MOUSE; CARDIAC MUSCLE CELL; CARDIOMEGALY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CARDIOMEGALY; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCYTES, CARDIAC; PHENYLEPHRINE; RNA, LONG NONCODING;

EID: 84990177935     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152767     Document Type: Article

References (23)

1. Carreno JE, Apablaza F, Ocaranza MP, Jalil JE (2006) [Cardiac hypertrophy: molecular and cellular events]. Rev Esp Cardiol 59: 473–486. PMID: 16750145
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345–352. PMID: 1825164
3. Chien KR, Knowlton KU, Zhu H, Chien S (1991) Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. Faseb J 5: 3037–3046. PMID: 1835945
4. Bishopric NH, Kedes L (1991) Adrenergic regulation of the skeletal alpha-actin gene promoter during myocardial cell hypertrophy. Proc Natl Acad Sci U S A 88: 2132–2136. PMID: 1826049
5. Gardner DG (2003) Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab 14: 411–416. PMID: 14580760
6. Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92: 1079–1088. PMID: 12775656
7. Qureshi IA, Mehler MF (2012) Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 13: 528–541. doi: 10.1038/nrn3234 PMID: 22814587
8. Thum T, Condorelli G (2014) Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ Res 116: 751–762.
9. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, et al. (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116: 258–267. PMID: 17606841
10. Matkovich SJ, Edwards JR, Grossenheider TC, de Guzman Strong C, Dorn GW 2nd (2014) Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs. Proc Natl Acad Sci U S A 111: 12264–12269. doi: 10.1073/pnas.1410622111 PMID: 25071214
11. Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, et al. (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42: 1113–1117. doi: 10.1038/ng.710 PMID: 21057500
12. Wang Y, Xu Z, Jiang J, Xu C, Kang J, et al. (2013) Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 25: 69–80. doi: 10.1016/j. devcel.2013.03.002 PMID: 23541921
13. Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, et al. (2013) The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 23: 340–350. doi: 10.1038/cr.2012.164 PMID: 23208419
14. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S (1992) Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J Biol Chem 267: 10551–10560. PMID: 1534087
15. Chen H, Wang X, Tong M, Wu D, Wu S, et al. (2013) Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy. PLoS One 8: e64757. doi: 10.1371/journal.pone. 0064757 PMID: 23737997
16. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, et al. (2000) Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 275: 37895–37901. PMID: 10984495
17. Hilfiker-Kleiner D, Hilfiker A, Castellazzi M, Wollert KC, Trautwein C, et al. (2006) JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity. Cardiovasc Res 71: 108–117. PMID: 16690042
18. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, et al. (2014) Cardiac fibroblast-derived micro-RNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124: 2136–2146. doi: 10.1172/JCI70577 PMID: 24743145
19. Abdellatif M (2010) The role of microRNA-133 in cardiac hypertrophy uncovered. Circ Res 106: 16–18. doi: 10.1161/CIRCRESAHA.109.212183 PMID: 20056941
20. Liu ZG, Tang B, Zeng Y, He N, Wang ZY, et al. (2015) Mitochondrial genome of a spontaneous multiple myeloma bone cancer model mouse C57BL/KaLwRij strain. Mitochondrial DNA: 1–2.
21. Wang N, Zhou Z, Liao X, Zhang T (2009) Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life 61: 566–571. doi: 10.1002/iub.204 PMID: 19472179
22. Da Costa Martins PA, De Windt LJ (2012) MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 93: 563–572. doi: 10.1093/cvr/cvs013 PMID: 22266752
23. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613–618. PMID: 17468766